Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Aug 2021 for Candel Therapeutics, Inc., €40k. Read the official filing
Filing timeline
BuySaleNathan Caffo
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+43.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Nathan Caffo: trading record in brief
Nathan Caffo has a single filing on record, published on 2 August 2021: an open-market purchase of €40k in Candel Therapeutics, Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nathan Caffo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
6,000 shares@ US$8.00100.0% of flowCommon StockSEC:0000899243-21-031086:0
Canonical exit: 27 Oct 2021 (T+90)
1 of 1 declaration
